iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.670
+0.080 (5.03%)
At close: Jun 26, 2026, 4:00 PM EDT
1.665
-0.005 (-0.31%)
After-hours: Jun 26, 2026, 7:58 PM EDT
iBio, Inc. Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for iBio, Inc. stock have an average target of 5.67, with a low estimate of 5.00 and a high estimate of 7.00. The average target predicts an increase of 239.52% from the current stock price of 1.67.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for iBio, Inc. stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 6 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Initiates $5 | Buy | Initiates | $5 | +199.40% | Jun 8, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $5 | Buy | Maintains | $5 | +199.40% | May 16, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +259.28% | May 15, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Maintains $6 | Buy | Maintains | $6 | +259.28% | May 14, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $5 | Buy | Reiterates | $5 | +199.40% | May 14, 2026 |
Financial Forecast
Revenue This Year
157.14K
from 400.00K
Decreased by -60.72%
Revenue Next Year
85.71K
from 157.14K
Decreased by -45.46%
EPS This Year
-0.33
from -1.75
EPS Next Year
-0.31
from -0.33
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 500,000 | 500,000 | |
| Avg | 157,140 | 85,710 | |
| Low | 100,000 | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 25.0% | 218.2% | |
| Avg | -60.7% | -45.5% | |
| Low | -75.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.25 | -0.22 | |
| Avg | -0.33 | -0.31 | |
| Low | -0.47 | -0.44 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.